A pharmacist-led specialty pharmacy model that expands into care management services could help health systems improve ...
Medicare Advantage 2027 updates boost payment updates near 5%, but risk rules and prior auth reforms force plans to rethink ...
The ACA individual exchange exit is positioned as a strategic de-emphasis of a shrinking line, with no 2026 network changes ...
Whole-mount immunolabeling enabled high-resolution visualization of peripheral nerve infiltration patterns within melanoma, ...
HealthDyne has 50,000 lives running through its direct-to-employer model but is eyeing a future of many more, according to ...
HealthDyne’s Sarah Thomas and David Skomo say that direct-to-patient arrangements eliminate opacity in drug pricing and allow ...
Retail blockbusters, then specialty drugs. Now a new era of mega-blockbusters | Asembia AXS26 Summit
The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...
A high-touch specialty pharmacy program that combines pharmacist support, telehealth and value-based care reduced medical ...
National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...
Skomo, chief operating officer for HealthDyne, and Thomas, head of growth and commercialization, led a session today about ...
PSG’s research found that payers are placing more attention on specialty drugs covered under the medical benefit, showing ...
Bipartisan legislative momentum and expanding litigation are accelerating PBM-focused reform at federal and state levels, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results